Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 209097
Company: CHARTWELL RX
Company: CHARTWELL RX
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
METHYLPREDNISOLONE | METHYLPREDNISOLONE | 2MG | TABLET;ORAL | Discontinued | None | No | No |
METHYLPREDNISOLONE | METHYLPREDNISOLONE | 4MG | TABLET;ORAL | Discontinued | None | No | No |
METHYLPREDNISOLONE | METHYLPREDNISOLONE | 8MG | TABLET;ORAL | Discontinued | None | No | No |
METHYLPREDNISOLONE | METHYLPREDNISOLONE | 16MG | TABLET;ORAL | Discontinued | None | No | No |
METHYLPREDNISOLONE | METHYLPREDNISOLONE | 32MG | TABLET;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
02/22/2019 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |